Daniel Ek: Life After Spotify, Broken Healthcare Incentives, Catching Disease Early & AI's Potential
Episode Details
In a recent episode of the All-In Podcast, host David Friedberg and co-host Chamath Palihapitiya engage with Daniel Ek on his journey in Entrepreneurship. Ek reflects on his early career optimizing Stardoll alongside Mattias Miksche, a venture supported by Index Ventures and Sequoia Capital. Ek then explains how rampant Music Piracy, fueled by platforms like Napster and Kazaa, inspired him and Martin Lorentzon to launch Spotify in Sweden. They convinced the RIAA to embrace streaming as a legal alternative to piracy and the lack of iTunes availability. Shifting to Healthcare, Ek discusses the systemic issues of the US Healthcare System and his new vertically integrated startup, Neko Health, co-founded with Hjalmar Nilsonne. Neko Health exemplifies Vertical Integration and aims to shift medicine towards Preventative Health to combat Chronic Disease. Utilizing Machine Learning and AI in Healthcare, the company collects longitudinal data, pulling inputs from Apple Health and popular Wearables such as Oura, Whoop, and Fitbit. Having proven its model in Sweden and the UK, Neko Health is expanding across the United States, with its first clinic in New York and upcoming locations in Miami and Washington DC. The conversation then explores the broader AI landscape, particularly LLMs. Ek evaluates the dynamic between Open Source AI (including Open-weight models) and Closed source AI, noting historical parallels to closed tech ecosystems like Apple. When debating AI Regulation, Ek argues that policymakers should focus on AI Compute Power and the sheer volume of GPU infrastructure required, rather than restricting open software. Lastly, Ek highlights how Spotify supports Open Standards in the distribution of Podcasts and briefly touches upon his investment firm, Prima Materia.
This episode features Daniel Ek discussing his entrepreneurial journey, from co-founding Spotify to launching his new healthcare venture, Neko Health. Key themes include the evolution of digital services, the challenges of disrupting established industries, and the potential of AI and data in transforming healthcare towards preventative and personalized medicine. The conversation also touches upon the broader AI landscape, including open-source vs. closed-source models and the role of compute power in AI development.
Portfolio lens: A basket of companies and themes focused on the intersection of technology and fundamental human needs, spanning preventative healthcare and the infrastructure powering advanced artificial intelligence.
Generated with gemini-2.5-flash-lite on 10/3/2026, 7:13:02 AM. For research only. Not financial advice.Neko Health: Vertical Integration in Preventative Healthcare
Neko Health's vertically integrated model, leveraging AI and longitudinal data collection, can significantly improve preventative healthcare outcomes and reduce long-term costs by shifting focus from reactive treatment to proactive health management.
Daniel Ek details Neko Health's approach of controlling the entire healthcare experience, from data collection (blood work, imaging) to clinician interaction, to identify health issues early and encourage lifestyle changes. The company has demonstrated success in Sweden and the UK and is expanding in the US, with a focus on chronic disease prevention.
- Neko Health is a vertically integrated healthcare experience, doing everything from building facilities to having doctors and nurses on staff, to building diagnostic equipment and software.
- The mission is to create the most valuable hour you can invest in your health.
- The experience includes measuring 53 blood markers, taking over 6,000 high-res images of the body to index moles and lesions, and assessing heart and blood circulation.
- Members get uninterrupted time with a clinician to go through results and discuss potential improvements.
- Around 1% of members have a serious underlying medical situation that is undiagnosed.
- People with the worst health status are improving the most, indicating the model's effectiveness in driving lifestyle changes.
- The company has done over 100,000 scans and published three years of data.
- Neko Health is expanding across the United States, with clinics in New York and upcoming locations in Miami and Washington DC.
- Successful expansion into new US markets (Miami, Washington DC, and beyond).
- Demonstration of long-term cost savings and improved health outcomes through published data.
- Partnerships with other health data providers or insurers.
- Further development and integration of AI for predictive diagnostics.
- High upfront cost of $499 per person may limit adoption for a significant portion of the population.
- Regulatory hurdles and complexities of the US healthcare system.
- Competition from other preventative health startups and traditional healthcare providers.
- Scalability challenges in replicating the vertically integrated model across diverse geographic locations.
- Analyze Neko Health's published data on health outcomes and cost savings.
- Investigate the unit economics and profitability of existing clinics.
- Track the pace and success of US market expansion.
- Research the competitive landscape of preventative health and diagnostic services.
AI Compute Power as a Regulatory Bottleneck
Regulating AI development by focusing on compute power, particularly GPU infrastructure, offers a more practical and effective approach than restricting open-source software, given the significant resource requirements for advanced AI model training.
Daniel Ek suggests that policymakers should consider the sheer volume of compute power and GPU infrastructure needed to train large AI models as a key metric for understanding and potentially regulating AI development, drawing parallels to historical concerns around supercomputers.
- Policymakers should focus on AI compute power and the sheer volume of GPU infrastructure required.
- This is a perspective that hasn't been heard much in debates, surprising the speaker.
- Historically, access to supercomputers like Cray was limited and considered a security risk due to their potential for designing nuclear weapons or cracking codes.
- The amount of compute used can indicate something about the power of a model.
- Using 100,000 GPUs for something is likely to be much more powerful than running an open-source model on a home PC.
- Compute as a roadblock is a good point, similar to how compute was a barrier for Cray supercomputers.
- Increased discussion and adoption of compute-centric AI regulation frameworks.
- Technological advancements that further increase the compute demands of AI models.
- Geopolitical factors influencing access to and control of GPU manufacturing and supply chains.
- Difficulty in accurately measuring and monitoring global compute usage.
- Potential for regulatory overreach that stifles innovation in both open-source and closed-source AI.
- The rapid decentralization of compute resources, making centralized control challenging.
- Focusing solely on compute might overlook other critical aspects of AI safety and ethics.
- Research existing proposals for AI regulation focusing on compute.
- Analyze the supply chain and geopolitical landscape of GPU manufacturing.
- Investigate the feasibility of monitoring and enforcing compute-based AI regulations.
- Compare the compute requirements of leading open-source and closed-source AI models.
Watchlist
- Neko Health's expansion progress in the US
- New data releases from Neko Health on health outcomes
- Developments in AI regulation focusing on compute power
- GPU supply chain dynamics and pricing
Open Questions
- What is the long-term cost-effectiveness of Neko Health's model compared to traditional healthcare?
- How will Neko Health navigate the complexities of insurance reimbursement in the US?
- What specific AI models and compute resources are being used by leading AI developers?
- How can compute power be effectively and equitably regulated without hindering innovation?
- What is the potential for Neko Health's data to contribute to broader medical research?
Key Topics & People
An investment firm started by Daniel Ek to fund deep technology and support ambitious founders.
Non-proprietary technological guidelines that allow interoperability, which Spotify supports in podcasting.
The physical processing power required to train AI models, proposed as a natural regulatory choke point.
The debate around how to safely govern and restrict AI systems, potentially focusing on compute.
Proprietary AI models heavily controlled by their creators, existing alongside open models.
AI models where the weights (parameters) are freely available, reducing costs and preventing tech monopolies.
AI models with accessible source code, which Ek advocates for to drive innovation.
Another target city for Neko Health's rapid US expansion.
.jpg?width=300){kind=avatar}
A major market for Spotify and Neko Health, noted for its complex and highly expensive healthcare system.
Apple's health informatics application, which Neko Health allows users to import data from.
The application of artificial intelligence to analyze patient data, track skin lesions, and improve health outcomes.
Algorithms utilized to analyze vast datasets for making medical predictions and uncovering insights.
Long-term health conditions that are a major driver of healthcare costs and can often be prevented if caught early.
A proactive approach to medicine aiming to identify and treat diseases early.
The complex and expensive medical system in the United States, currently oriented towards reactive care.
A business strategy utilized by Neko Health to control the entire patient experience, from clinics to software.
Co-founder and CEO of Neko Health, leading the company's daily operations (transcribed contextually as 'Yael Mar').
A health technology company co-founded by Daniel Ek focusing on proactive, data-driven preventative care.
A massive industry and expense in the US economy, which Neko Health aims to innovate.
Co-founder of Spotify who brainstormed the idea with Daniel Ek.
The illegal downloading of music, which heavily impacted the recording industry and sparked the creation of Spotify.
A prominent venture capital firm that invested in Stardoll after its technical restructuring.
A venture capital firm that invested in Stardoll and helped rebrand it.
A Swedish entrepreneur who recruited Daniel Ek to help build and scale Stardoll.
The journey and challenges of building startups, which Daniel Ek discusses regarding Spotify and Neko Health.
_(cropped).jpg?width=300){kind=avatar}
.jpg?width=300){kind=avatar}
Venture capitalist and co-host of the All-In Podcast, mentioned in the context of investing philosophy.
Co-host of the All-In Podcast and venture capitalist who interviewed Daniel Ek.
A popular technology and business podcast where industry leaders discuss startups, economy, and global events.